Lakeev Alexander P, Frelikh Galina A, Yanovskaya Elena A, Kovrizhina Anastasia R, Udut Vladimir V
Goldberg Research Institute of Pharmacology & Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, 634028, Russia.
National Research Tomsk State University, Tomsk, 634050, Russia.
Bioanalysis. 2022 Nov;14(22):1423-1441. doi: 10.4155/bio-2022-0193. Epub 2023 Jan 27.
IQ-1 is a promising c-Jun-N-terminal kinase inhibitor and nitrovasodilator. An LC-MS/MS method was validated to determine IQ-1 isomers and major metabolite IQ-18 in rat plasma. The analytes were extracted using ethyl acetate. The chromatographic separation was performed on a C8 column (150 × 4.6 mm, 5 μm) under acetonitrile-water (5 mM ammonium formate buffer, pH 2.93) gradient elution. Multiple reaction monitoring was used for MS/MS detection in the positive ion mode. The method was fully validated over the range of 0.1-400 ng/ml (-isomer), 0.9-3600 ng/ml (-isomer), 5.0-4000 (IQ-18). This method has been successfully applied to pharmacokinetic studies of IQ-1 and IQ-18 in rats after a single oral dose of IQ-1 (50 mg/kg).
IQ-1是一种有前景的c-Jun氨基末端激酶抑制剂和硝基血管舒张剂。已验证一种液相色谱-串联质谱法用于测定大鼠血浆中的IQ-1异构体和主要代谢物IQ-18。分析物用乙酸乙酯提取。在C8柱(150×4.6 mm,5μm)上,以乙腈-水(5 mM甲酸铵缓冲液,pH 2.93)梯度洗脱进行色谱分离。在正离子模式下,采用多反应监测进行串联质谱检测。该方法在0.1-400 ng/ml(-异构体)、0.9-3600 ng/ml(-异构体)、5.0-4000(IQ-18)范围内得到充分验证。该方法已成功应用于大鼠单次口服IQ-1(50 mg/kg)后IQ-1和IQ-18的药代动力学研究。